Loading company…
Xiamen AmonMed develops and sells fluorescence immunoassay analyzers, diagnostic kits and medical testing services.
Founded in 2014 and based in Xiamen, China, Xiamen AmonMed Biotechnology develops, produces and sells nano-fluorescence immunoassay analyzers and diagnostic kits, and provides third-party medical testing. Its products include POCT instruments, fluorescence immunoassays and colloidal gold tests, including COVID-19 and influenza test kits. The company reported 12 medical patents, 38 in vitro diagnostic reagents and 34 products with EU CE certification. It received ISO 13485:2016 registration certification in 2019.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in